Back to company

COREMEDICO ApS: Financial statements 2022

CVR: 30070534

COREMEDICO ApS (CVR 30070534) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,063 and a net result of DKK -62,624 compared with DKK -171,088 the year before. Equity amounted to DKK 326,489. The solvency ratio was 32.3%.

Gross Profit
-10,063 kr.
Profit/Loss
-62,624 kr.
Equity
326,489 kr.
Total Assets
1,012,068 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--10 t.-63 t.326 t.0
2021--20 t.-171 t.389 t.0
2020-31 t.-15 t.560 t.0
2019-76 t.1 t.576 t.0
2018-26 t.-31 t.-426 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on COREMEDICO ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

COREMEDICO ApS: The 2021 annual report is outJun 8, 2022

COREMEDICO ApS has published its annual report for 2021. Gross profit came to DKK -19,814, and the net result was DKK -171,088.

About COREMEDICO ApS

COREMEDICO ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2006. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kevin Hagemann Petersen. The company is owned by JOSARDI ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK -71,962 and a net result of DKK -781,873 compared with DKK -774,332 the year before. Equity amounted to DKK 1,278,734.